Aims. Treatment of end-stage
A sibling risk study that shows a statistically significant increase in risk for
Introduction: This study explores whether modern magnetic resonance imaging (MRI) with improved cartilage sequencing is able to show a more detailed view of
Introduction: This study explores whether modern magnetic resonance imaging (MRI) with improved cartilage sequencing is able to show a more detailed view of antero-medial osteoarthritis of the knee (AMOA) than previously, so enabling a radiographic description of this common phenotype of disease. Modern MRI technology allows us to visualize in great detail the structures and cartilage within the knee, providing a better understanding of the pathoanatomy of AMOA. This description of the end stage of disease is useful as a baseline when investigating the progression of arthritis through the knee. Preoperative assessment of patients and selection of intervention is very important and preoperative imaging forms an integral part of this. This will also be useful in preoperative assessment and surgical management of patients. Methods: 50 patients with a radiographic diagnosis of
Aim: To investigate the molecular features of progressive severities of cartilage damage, within the phenotype of
The aim of this study was to investigate the molecular features of progressive severities of cartilage damage, within the phenotype of
Our aim was to investigate the molecular features of progressive severities of cartilage damage, within the phenotype of Anteromedial Gonarthrosis (AMG). Ten medial tibial plateau specimens were collected from patients undergoing unicompartmental knee replacements. The cartilage within the area of macroscopic damage was divided into equal thirds: T1(most damaged), to T3 (least damaged). The area of macroscopically undamaged cartilage was taken as a 4th sample, N. The specimens were prepared for histological (Safranin-O and H&
E staining) and immunohistochemical analysis (Type I and II Collagen, proliferation and apoptosis). Immunoassays were undertaken for Collagens I and II and GAG content. Real time PCR compared gene expression between areas T and N. There was a decrease in OARSI grade across the four areas, with progressively less fibrillation between areas T1, T2 and T3. Area N had an OARSI grade of 0 (normal). The GAG immunoassay showed decreased levels with increasing severity of cartilage damage (p<
0.0001). There was no significant difference in the Collagen II content or gene expression between areas. The Collagen I immunohistochemistry showed increased staining within chondrocyte pericellular areas in the undamaged region (N) and immunoassays showed that the Collagen I content of this macroscopically and histologically normal cartilage, was significantly higher than the damaged areas (p<
0.0001). Furthermore, real time PCR showed a significant increase in Collagen I expression in the macroscopically normal areas compared to the damaged areas (p=0.04). In AMG there are distinct areas, demonstrating progressive cartilage loss. We conclude that in this phenotype the Collagen I increase, in areas of macroscopically and histologically normal cartilage, may represent very early changes of the cartilage matrix within the osteoarthritic disease process. This may be able to be used as an assay of early disease and as a therapeutic target for disease modification or treatment.
Abstract. Background. Since 2012 we have routinely used the cementless Oxford medial unicompartmental knee arthroplasty (mUKA), with microplasty instrumentation, in patients with
The purpose of this study was to establish the long-term clinical outcome of the Oxford Medial Unicompartmental Knee Arthroplasty (UKA). Methods: A continuous series of 420 patients underwent medial Oxford UKA. Indications were
Introduction: The use of the Oxford Phase 3 unicompartmental knee arthroplasty (UKA) in the treatment of
This is a study of the quality of outcome of the first 100 patients who received the Twin Peg Oxford Partial knee replacement; which has been designed with a 15 degree extra surface for contact in deep flexion, and two pins for more secure fixation. We measured the outcome in patients with
Enhanced appreciation of normal knee kinematics and the inability to replicate these in the replaced total knee has led to increased enthusiasm for partial knee arthroplasty by some. These arthroplasties more closely replicate normal kinematics since they inherently preserve the anterior cruciate ligament (ACL). Indications for medial UKA are:
About ten years ago we introduced sophisticated instrumentation and an increased range of component sizes for the Oxford unicompartmental knee replacement (UKR) to facilitate a minimally invasive surgical (MIS) approach. The device is now routinely implanted through an incision from the medial pole of the patella to the tibial tuberosity. This has resulted in a more rapid recovery and an improved functional result. As the access to the knee is limited there is a concern that the long term results may be compromised. The aim of this study was to determine the 10 year survival. A prospective follow up of all Phase 3 minimally invasive Oxford UKR implanted by two senior authors (DWM &
CAFD) has been undertaken. So far 1015 UKRs have been implanted for
Aims: To evaluate the outcome of 135 Oxford Unicompartmental Knee replacements with regards to knee function and implant survival. Methods: 135 Oxford unicompartmental knee replacements were performed by a single surgeon between 1989–2000. Indication was anteromedial knee osteoarthritis with a correctable varus deformity and intact anterior cruciate ligament. The patients were evaluated in clinic both clinically &
radiologically. Modiþed Knee Society Score was used to evaluate knee function. X-rays were performed to look for implant loosening and progression of arthritis. Results: 29 patients died and 5 were too ill to attend clinic. A total of 5 revisions were carried out. There were 53 male and 43 females. 74% patients were betweem 60 Ð 80 yrs. Follow up ranged from 1–11 yrs with a mean follow up of 5.2 yrs. 88% patients had range of movement of more than 105 degrees. The mean Total Knee Score was 92 and the mean functional knee score was 76. Blood transfusion was not necessary in 90% of patients. Superþcial wound infection was noted in 2 cases and hematoma formation in 4 cases. Tibial component loosening was the cause for revision. Conclusions: 1. With appropriate patient selection Oxford unicompartmental knee is a reliable treatment option for
Purpose: This study was designed to establish the poly-ethylene wear rates in the Oxford medial unicompert-mental knee replacement. Introduction: The Oxford meniscal bearing knee was introduced as a design to reduce polyethylene wear. There has been one previous retrieval study of the Oxford UKA, which reported very low wear rates in some specimens, but abnormal patterns of wear in others, including impingement. There has been no further investigation of these abnormal wear patterns. Methods: Forty-seven bearings were retrieved from patients who had received a medial Oxford UKA for
Unicompartmental knee replacement (UKR) is an established treatment for single compartment end-stage arthrosis with good recorded survivorship. UKRs are often implanted into more active younger patients, but patient selection remains controversial. A recent study, led by the Royal College of Surgeons Clinical Effectiveness Unit, demonstrated that prosthesis revision rates decrease strongly with age (Van Der Meulen et al 2008). It has therefore been suggested that UKR should only be considered in elderly patients. This contrasts our observed experience of early revision cases leading us to compare these patients with a control group. Between September 2002 and 2008, 812 Oxford Mobile Bearing Medial UKRs were implanted. We compared all patients who underwent UKR revision to Total Knee Replacement (TKR) against a control group of 50 consecutive UKR patients. 20 implants have required revision to TKR in 19 patients since 2002. Median age at index surgery was 68 (range 48-81), median BMI was 31 (range 25-41.5), 17 patients were female (85%), and median implant survival was 25 months (range 6-57). Control group median age at index surgery was 66 (range 46-81), median BMI was 30 (range 22-51), and 27 patients were female (54%). Median Oxford Knee Score recorded in September 2009 was 36 (range 14-54) for revision patients and 21 (range 14-39) for the control group (p=0.021). Our UKR patients with early failure requiring revision are far more likely to be female (p=0.015), as well as older and with a higher BMI than the control group. We feel this is a subset of patients at high risk of failure, despite meeting all criteria for UKR. The underlying causes are likely to be multifactorial, but a key factor may be that this group has varus tricompartment osteoarthritis rather than classical
To report a 15-year survival analysis of the Oxford Medial Unicompartmental Knee Arthroplasty (Oxford UKA) in an independent series. We report the results of a series of 420 Oxford UKAs performed between 1983 and 2000. Indications for surgery were primary antero-medial osteoarthritis of the knee with an intact ACL, correctable varus deformity of <
15° and <
15° fixed flexion deformity. The state of the patello-femoral joint was not used as a selection criterion. Patients were contacted by a postal questionnaire or by telephone. The outcome of all 420 knees was established, with none lost to follow-up. Seventy-six knees were in patients who had died and the state of each arthroplasty was determined from hospital and GP records. Seventeen patients (4%) had required revision. Indications for revision were lateral compartment arthrosis (7), component loosening (4), bearing dislocation (4) and infection (2). There were no failures for polyethylene wear. Cumulative survival at 15 years was 94.3% [95% CI 3.8%]. The worst case scenario was 94.3% as none were lost to follow-up. The results from an independent series are important, as they avoid bias. The 15-year results of this independent series are better than any other reported series of unicompartmental device at 15 years and as good as the published independent 15 year survival results for total knee arthroplasty. The data illustrates that excellent long-term survival can be achieved with the Oxford UKA, allowing patients to benefit from the advantages that unicompartmental arthroplasty offers. We believe that provided patients are selected appropriately, this device provides the treatment of choice for
We report the outcome of 58 knees with